Abstract
Diabetes is a complex disease, and patients face barriers to reaching glycosylated hemoglobin (HgbA1c) goals. A retrospective cohort chart review evaluated if the cost of diabetes medications is a barrier to glycemic goals in uninsured patients receiving reduced-cost medications. Thirty-five patients were followed over 6 months to determine the association between HgbA1c and medication possession, monthly income, drug costs/month/patient, and poverty level. Higher HgbA1c was associated with higher drug cost/month (P = 0.005), but better medication possession was not associated with lower HgbA1c levels. Providers should tailor care to address factors (other than cost) known to influence HgbA1c.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
